Approval · Notice of Compliance 25745 · 2021
POLIVY: Notice of Compliance 25745
Issued April 27, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25745
- Date
- April 27, 2021
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New fill volume and additional manufacturing facility
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| POLIVY | 02515431 | Marketed |
Medicinal ingredients
- POLATUZUMAB VEDOTIN 140 MG per VIAL
- POLATUZUMAB VEDOTIN 30 MG per VIAL